Gossamer Bio, Inc. (GOSS) Stock Overview
Explore Gossamer Bio, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Gossamer Bio, Inc. (GOSS)
Key Financials
Key Financials
Market Cap
68.9M
P/E Ratio
-0.25
EPS (TTM)
$-0.70
ROE
1.09%
GOSS Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Gossamer Bio, Inc. (NASDAQ: GOSS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Gossamer Bio, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of GOSS on the NASDAQ shows an RSI of 72.13, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $1.02 for the NASDAQ listing.
Key metrics behind Gossamer Bio, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.25 and a market capitalization of 68.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of GOSS on the NASDAQ.